Autophagy contributes to the chemo-resistance of non-small cell lung cancer in hypoxic conditions

被引:66
|
作者
Lee, Jin Gu [1 ]
Shin, Ju Hye [2 ]
Shim, Hyo Sup [3 ]
Lee, Chang Young [1 ]
Kim, Dae Joon [1 ]
Kim, Young Sam [2 ]
Chung, Kyung Young [1 ]
机构
[1] Yonsei Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul, South Korea
[2] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[3] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea
来源
RESPIRATORY RESEARCH | 2015年 / 16卷
关键词
Autophagy; Chemotherapy; Hypoxia; Lung cancer; Resistance; DECREASED EXPRESSION; TUMOR HYPOXIA; SURVIVAL; BECLIN-1; PROLIFERATION; PROTEINS; BNIP3; HIF-1; LC3;
D O I
10.1186/s12931-015-0285-4
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: The development of chemo-resistance in non-small lung cancer is a major obstacle in treating patients. Hypoxia is a commonly faced microenvironment in solid tumor and suggested to be related to both autophagy and chemo-resistance. Methods: In this study, we investigated the role of hypoxia-induced autophagy in acquiring chemo-resistance in both cancer cell (A549) and human cancer tissue Results: Hypoxic exposure (1 % O2) of A549 cell stimulated autophagic induction in cancer cells, shown by increase of LC3BI to LC3BII conversion and decrease of p62/sequestosome1 in Western blot, increased GFP-LC puncta in confocal microscopy, and increased number of double-membrane autophagic vacuoles in electron micrographs. Hypoxic exposure also induced resistance of cancer cells to cisplatin, and LC3B siRNA restored the sensitivity of cancer cells to chemotherapy. Furthermore, Human lung cancer tissues that experienced chemotherapy showed increase of LC3BI to LC3BII conversion and decrease of p62/sequestosome1 compared with chemo-naive cancer tissue in Western blot. Conclusion: Autophagy may play an important role in acquiring resistance to chemotherapy in lung cancer and hypoxia related pathway seems to be involved in autophagy induction.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Non-small cell lung cancer
    Nestle, U.
    Hoffmann, H.
    Reck, M.
    Bruns, C.
    ONKOLOGIE, 2022, 28 (12): : 1034 - 1037
  • [42] Non-small cell lung cancer
    Sause, W
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (02): : 126 - 126
  • [43] Non-Small Cell Lung Cancer
    Ettinger, David S.
    Akerley, Wallace
    Borghaei, Hossein
    Chang, Andrew C.
    Cheney, Richard T.
    Chirieac, Lucian R.
    D'Amico, Thomas A.
    Demmy, Todd L.
    Ganti, Apar Kishor P.
    Govindan, Ramaswamy
    Grannis, Frederic W., Jr.
    Horn, Leora
    Jahan, Thierry M.
    Jahanzeb, Mohammad
    Kessinger, Anne
    Komaki, Ritsuko
    Kong, Feng-Ming
    Kris, Mark G.
    Krug, Lee M.
    Lennes, Inga T.
    Loo, Billy W., Jr.
    Martins, Renato
    O'Malley, Janis
    Osarogiagbon, Raymond U.
    Otterson, Gregory A.
    Patel, Jyoti D.
    Pinder-Schenck, Mary C.
    Pisters, Katherine M.
    Reckamp, Karen
    Riely, Gregory J.
    Rohren, Eric
    Swanson, Scott J.
    Wood, Douglas E.
    Yang, Stephen C.
    Hughes, Miranda
    Gregory, Kristina M.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2012, 10 (10): : 1236 - 1271
  • [44] Non-small cell lung cancer
    M. Dediu
    W. Hilbe
    memo - Magazine of European Medical Oncology, 2008, 1 (4) : 247 - 251
  • [45] Non-small cell lung cancer
    Adamietz, I. A.
    Niederle, N.
    ONKOLOGE, 2010, 16 (06): : 63 - 74
  • [46] HMGB1-mediated autophagy promotes gefitinib resistance in human non-small cell lung cancer
    Lei, Tianyao
    Huang, Jiali
    Xie, Fei
    Gu, Jingyao
    Cheng, Zhixiang
    Wang, Zhaoxia
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2022, 54 (04) : 514 - 523
  • [47] HMGB1-mediated Autophagy Promotes Gefitinib Resistance in Human Non-small Cell Lung Cancer
    Lei, T.
    Xu, T.
    Zou, X.
    Zhang, N.
    Wei, C.
    Wang, Z.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S620 - S620
  • [48] ;Non-small cell lung cancer
    Dediu, M.
    Hilbe, W.
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2008, 1 (04) : 247 - 251
  • [49] Chemo-radiotherapy versus chemo-surgery in stage IIIA non-small cell lung cancer
    Stathopoulos, GP
    Papakostas, P
    Malamos, NA
    Samelis, GF
    Moschopoulos, N
    ONCOLOGY REPORTS, 1996, 3 (04) : 673 - 676
  • [50] Transformation of Non-Small Cell Lung Cancer (NSCLC) to Small Cell Lung Cancer (SCLC), Mechanism of Treatment Resistance?
    Hamedi, Z.
    Kamboj, S.
    Kumar, S.
    Jiwani, R. A.
    Sharma, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)